Marathon Capital Management’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-11,910
Closed -$464K 96
2016
Q2
$464K Hold
11,910
0.24% 45
2016
Q1
$363K Sell
11,910
-1,405
-11% -$32.3K 0.19% 52
2015
Q4
$338K Sell
13,315
-6,130
-32% -$224K 0.18% 52
2015
Q3
$626K Sell
19,445
-305
-2% -$11.7K 0.32% 42
2015
Q2
$1.09M Sell
19,750
-330
-2% -$21K 0.5% 33
2015
Q1
$1.12M Buy
20,080
+90
+0.5% +$5.66K 0.5% 30
2014
Q4
$1.39M Buy
19,990
+1,980
+11% +$169K 1.28% 24
2014
Q3
$1.91M Buy
18,010
+965
+6% +$106K 1.72% 17
2014
Q2
$2.02M Buy
17,045
+4,255
+33% +$493K 1.63% 21
2014
Q1
$1.37M Buy
12,790
+170
+1% +$16.1K 1.03% 28
2013
Q4
$1.14M Buy
12,620
+2,100
+20% +$191K 0.82% 30
2013
Q3
$912K Buy
10,520
+270
+3% +$23.5K 0.78% 31
2013
Q2
$868K Buy
+10,250
New +$949K 0.74% 32

Other funds holding OVV

Marathon Capital Management's OVV Position: Q3 2016 in Review

Marathon Capital Management sold out of Ovintiv (OVV) in Q3 2016, closing a stake of 11,910 shares — an estimated $464K sold.

Marathon Capital Management first reported a position in OVV in Q2 2013 and held it in 13 quarters. The position peaked at $2.02M in Q2 2014. 335 funds tracked by Wall St. Rank hold OVV as of Q3 2016.

  • Marathon Capital Management reported no remaining Ovintiv position as of Q3 2016 after selling out during the quarter.
  • Marathon Capital Management sold 11,910 Ovintiv shares in Q3 2016, an estimated $464K.
  • Marathon Capital Management first reported a position in Ovintiv in Q2 2013 and held it in 13 quarters.
  • Marathon Capital Management's Ovintiv position peaked at $2.02M in Q2 2014.
  • 335 funds tracked by Wall St. Rank held Ovintiv as of Q3 2016.

Based on Marathon Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.